Odyssey Health (ODYY) Cash & Equivalents (QoQ) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Odyssey Health | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jan 31, 2026 | 2,308.84% |
| Oct 31, 2025 | 34.07% |
| Jul 31, 2025 | 499.00% |
| Apr 30, 2025 | -55.67% |
| Jan 31, 2025 | -86.66% |
| Oct 31, 2024 | 2,164.19% |
| Jul 31, 2024 | -96.40% |
| Apr 30, 2024 | -60.27% |
| Jan 31, 2024 | -16.04% |
| Oct 31, 2023 | 436.77% |
| Jul 31, 2023 | 2,887.44% |
| Apr 30, 2023 | -96.55% |
| Jan 31, 2023 | -29.12% |
| Oct 31, 2022 | -30.38% |
| Jul 31, 2022 | -72.76% |
| Apr 30, 2022 | 102.76% |
| Jan 31, 2022 | -72.12% |
| Oct 31, 2021 | 549.54% |
| Jul 31, 2021 | -94.74% |
| Apr 30, 2021 | 2,085.16% |
| Jan 31, 2021 | -78.46% |
| Oct 31, 2020 | -47.40% |
| Jul 31, 2020 | 1,989.12% |
| Apr 30, 2020 | 865.64% |
| Jan 31, 2020 | -97.30% |
| Oct 31, 2019 | -38.77% |
| Jul 31, 2019 | 50,843.60% |
| Apr 30, 2019 | -47.85% |
| Jan 31, 2019 | -37.41% |
| Oct 31, 2018 | 157.69% |
| Jul 31, 2018 | -93.65% |
| Apr 30, 2018 | 1,424.07% |
| Jan 31, 2018 | -96.50% |
| Oct 31, 2017 | -14.13% |
| Jul 31, 2017 | 457.10% |
| Apr 30, 2017 | -70.04% |
| Jan 31, 2017 | 1,218.52% |
| Oct 31, 2016 | -72.03% |
| Jul 31, 2016 | -85.39% |
| Apr 30, 2016 | 860.81% |
| Jan 31, 2016 | -73.17% |
| Oct 31, 2015 | 8.28% |
| Jul 31, 2015 | -14.74% |
| Apr 30, 2015 | -82.50% |
| Jan 31, 2015 | -21.94% |
| Oct 31, 2014 | -0.11% |